EPCAM and lung carcinoma: Promoter methylation was one of the mechanisms accounting for EpCAM repression in highly metastatic lung cancer cell A549, which was evidenced by strong restoration of EpCAM expression by DNMT inhibitor 5-aza-dC in both time- and dose-dependent manners (Figure 6A).